Free indicative estimate
Answer seven questions for an instant, non-binding value range based on a simplified relief-from-royalty model. Every assumption is shown — nothing is hidden.
Indicative range · non-binding
Relief-from-royalty (simplified)₹1.11 Cr
Base indication
This is not a valuation. It is an automated, non-binding estimate from a simplified model and your inputs, for orientation only. It must not be relied on for any transaction, financial reporting, tax, legal or regulatory purpose. For a fuller view, order a preliminary valuation report prepared and reviewed by our analysts.
After-tax royalty savings, discounted to today
| Year | Revenue | After-tax royalty | Discount factor | PV |
|---|---|---|---|---|
| 1 | ₹5 Cr | ₹18.71 L | 0.9054 | ₹16.94 L |
| 2 | ₹5.5 Cr | ₹20.58 L | 0.7421 | ₹15.27 L |
| 3 | ₹6.05 Cr | ₹22.64 L | 0.6083 | ₹13.77 L |
| 4 | ₹6.66 Cr | ₹24.9 L | 0.4986 | ₹12.41 L |
| 5 | ₹7.32 Cr | ₹27.39 L | 0.4087 | ₹11.19 L |
| 6 | ₹8.05 Cr | ₹30.13 L | 0.3350 | ₹10.09 L |
| 7 | ₹8.86 Cr | ₹33.14 L | 0.2746 | ₹9.1 L |
| 8 | ₹9.74 Cr | ₹36.46 L | 0.2251 | ₹8.2 L |
| 9 | ₹10.72 Cr | ₹40.1 L | 0.1845 | ₹7.4 L |
| 10 | ₹11.79 Cr | ₹44.11 L | 0.1512 | ₹6.67 L |
Centre line = base estimate ₹1.11 Cr
| Driver | Low input | Value | High input | Value |
|---|---|---|---|---|
| Royalty rate ±20% | 4.0% | ₹88.84 L | 6.0% | ₹1.33 Cr |
| Useful life ±2 yrs | 8 yrs | ₹96.98 L | 12 yrs | ₹1.22 Cr |
| Discount rate ±3 pts | 25.0% | ₹1.01 Cr | 19.0% | ₹1.23 Cr |
| Revenue growth ±3 pts | 7.0% | ₹1.01 Cr | 13.0% | ₹1.23 Cr |
| Method | Relief-from-royalty (simplified) | Methodology page, section D |
|---|---|---|
| Royalty rate | 5.0% | Illustrative Medical devices & diagnostics band 3.0%–8.0%, positioned by your strength score |
| Discount rate | 22.0% | Stage benchmark for "Early revenue" |
| Tax rate | 25.2% | Indian domestic company concessional rate (incl. surcharge & cess) |
| Useful life | 10 years | Your input, capped at 20 years for patent |
| Growth | 10.0% | Your input, constant over life |
| Excluded | TAB, probability weighting, obsolescence | Included in full reports |
A preliminary report applies multiple methods, verified data, Monte Carlo and sensitivity testing, and a second review.